1 - 2 / 2 1 |
1. Discovery of desmuramylpeptide NOD2 agonists with single-digit nanomolar potency Samo Guzelj, Špela Bizjak, Žiga Jakopin, 2022, izvirni znanstveni članek Ključne besede: NOD2, desmuramylpeptide, immunostimulant, adamantane, PBMC cytotoxicity, K562, agonists, cells, peptides and proteins, reaction products, toxicological synergy |
2. Lipidation of NOD2 agonists with adamantane and stearoyl moieties differentially regulates their In vivo adjuvant activity Samo Guzelj, Marcela Šišić, Špela Bizjak, Leo Frkanec, Ruža Frkanec, Žiga Jakopin, 2022, izvirni znanstveni članek Ključne besede: NOD2 agonist, vaccine adjuvant, adamantane, immunopotentiators, desmuramylpeptides |